Antibiotics given in different ways for hospital sepsis
Part of Infections clinical trials.
This study tests whether giving certain antibiotics intermittently versus continuously, along with a second antibiotic, works better for hospital-acquired sepsis. It may help doctors choose the most effective way to control serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older).
- You were diagnosed with sepsis in the last 24 hours while in the hospital (or you were discharged within the last 48 hours).
- You have a high risk for hard-to-treat “Gram-negative” germs that resist many antibiotics (for example, recent IV antibiotics, long hospital stay, medical devices like a urinary catheter/lines/ventilator, or known MDR germs).
- A sample from your infection (like blood or other cultures) was taken before starting the study antibiotics.
- You are expected to be in the ICU for more than 3 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two antibiotics—piperacillin-tazobactam or temocillin—to treat severe ICU infections caused by certain hard-to-treat gut bacteria (ESBL). It may help patients avoid the use of carbapenem antibiotics like meropenem when the bacteria are susceptible.
This trial tests whether giving a certain type of antibiotic (beta-lactam) continuously or intermittently works better for patients in the intensive care unit with pneumonia or a urinary tract infection and signs of sepsis. Sepsis is a serious response to an infection, so better antibiotic delivery could improve outcomes.
This trial checks if giving higher doses of beta-lactam antibiotics (a type of strong antibiotic) right from the start helps people in the ICU with septic shock. It aims to find the best dose to fight the infection quickly.
This trial compares giving a long, continuous infusion versus standard short infusions of certain antibiotics (beta-lactams) to children with sepsis in intensive care. The goal is to find which method works better and is safer.
This trial tests a computer tool to help doctors choose the right antibiotic for sepsis early on. It may help improve treatment by providing personalized recommendations based on your condition.
This trial tests a type of antibiotic called aminoglycosides to treat early sepsis (a serious infection). It is for adults in the hospital who are sick enough to need strong antibiotics but not in the worst stage of the illness.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.